Brief: Clarity Pharmaceuticals Confirms No Supply Issues To Its Clinical Trials
10/05/2022 09:30
May 10 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX :
* CLARITY PHARMACEUTICALS LTD - CLARITY CONFIRMS NO SUPPLY
ISSUES
TO ITS CLINICAL TRIALS-CU6.AX
* CLARITY PHARMA - CONFIRMS CLARITY, CLINICAL DEVELOPMENT
PROGRAMS
UNAFFECTED BY NOVARTIS' SUSPENSION OF PRODUCTION AT FACILITIES
IN ITALY, NEW JERSEY
Source text for Eikon: ID:nASX2QTwYV
Further company coverage: CU6.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial